Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green Gold Biotech, also known as Green Gold Global Group, is a prominent biotechnology company specializing in the large-scale extraction and purification of botanical compounds, specifically industrial hemp-derived cannabinoids. Based in Anji, China, the company operates high-tech facilities dedicated to producing pharmaceutical-grade CBD, CBG, and other minor cannabinoids. They utilize proprietary supercritical CO2 extraction and advanced chromatography technologies to ensure high purity and safety standards for their ingredients. The company serves the global pharmaceutical, nutraceutical, and cosmetic industries by providing broad-spectrum oils and isolates. Green Gold Biotech is also involved in research and development to explore the clinical benefits of phytochemicals in treating pain and neurological conditions. Their business model integrates cultivation oversight with advanced manufacturing to maintain a consistent supply chain for international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Gold Biotech.